Procter & Gamble exceeded earnings expectations with a $0.02 EPS beat and raised full-year guidance, signaling strong operational performance. Market share gains across key segments and the successful launch of Fusion highlight positive momentum. While acknowledging competitive pressures and a slight slowdown in China, the overall solid outlook suggests a positive short-term impact on the stock price.

[1]